Indications for: CETROTIDE

Inhibition of premature LH surges in women undergoing controlled ovarian stimulation for in vitro fertilization.

Adult Dosage:

Give by SC inj into lower abdominal wall during early to mid-follicular phase; see full labeling. 0.25mg daily beginning on stimulation day 5 (morning or evening) or day 6 (morning) and continue until day of hCG administration.

Children Dosage:

Not applicable.

CETROTIDE Contraindications:

Pregnancy (Cat.X). Nursing mothers.

CETROTIDE Warnings/Precautions:

Do complete gynecological and endocrinological exam first.

CETROTIDE Classification:

GnRH antagonist.

Adverse Reactions:

Ovarian hyperstimulation syndrome, nausea, headache, inj site reactions, elevated enzymes (eg, ALT, alkaline phosphatase).

How Supplied:

Vial—1 (w. diluent, supplies)